Moira Rynn, MD
Ruane Professor for the Implementation of Science for Child and Adolescent Mental Health in Psychiatry at the Columbia University Medical Center
Director of the Division Child and Adolescent Psychiatry
Unit Chief of Children’s Research Day Unit, New York State Psychiatric Institute/Columbia University
Medical Director of The Columbia University Clinic for Anxiety and Related Disorders, CUCARD
Director of the Child and Adolescent Psychiatric Evaluation Service , New York State Psychiatric Institute/Columbia University
Dr. Moira Rynn is Director of the Division of Child and Adolescent Psychiatry, Department of Psychiatry at Columbia University (CU)/ New York State Psychiatric Institute (NYSPI). She is the Medical Director of The Columbia University Clinic for Anxiety and Related Disorders (CUCARD) and Director of the Children’s Day Unit and the Child and Adolescent Psychiatric Evaluation Service at NYSPI and CU. Dr. Rynn was recruited to NYSPI/CU in 2006.
Previously she had been the Medical Director of the Mood and Anxiety Disorders Section of the Department of Psychiatry at the University of Pennsylvania School Of Medicine (PENN) since 1998. Dr. Rynn joined the Department of Psychiatry at PENN in 1991 as a resident. In 1997, she completed the Child and Adolescent Psychiatry Fellowship at the Children’s Hospital of Philadelphia, Child Guidance Center, followed by a Neuropsychopharmacology Research Fellowship, sponsored by the NIMH at PENN.
Dr. Rynn specializes in the treatment of anxiety and mood disorders, as well as Obsessive-Compulsive Disorder in children, adolescents, and young adults.
CUMC/Neurological Institute of New York
710 West 168th Street
Floor: 12 New York, NY 10032
Phone: (212) 305-6001
Public Transportation: Yes
Disabled Access: Yes
Dr. Rynn’s area of research has been focused on pediatric psychopharmacology with an emphasis on mood and anxiety disorders. Dr. Rynn completed several studies in the area of pediatric anxiety studies showing the efficacy of sertraline (Rynn et al., AJP, 2001) and venlafaxine ER (AJP, 2007). Dr. Rynn participated as an investigator in the Pediatric OCD Treatment Study (POTS) Team (JAMA, 2004). Dr. Rynn as Co-Principal Investigator worked with Dr. Anne Marie Albano (Principal Investigator) on the largest published study in pediatric anxiety disorders, the Child Child/Adolescent Anxiety Multimodal Treatment Study (CAMS, NEJM, 2008) which showed the treatment efficacy of the combination of cognitive behavioral therapy and medication.
In addition she is examining the efficacy of novel compounds for the treatment of pediatric obsessive compulsive disorder. Dr. Rynn has been providing pharmacologic treatment for adults and children diagnosed with mood and anxiety disorders since 1991.
Dr. Rynn is interested in treating children and adolescents who have failed first line treatments for mood and anxiety disorders.